SHOREVIEW, Minn., Sept. 28, 2019 /PRNewswire/ — OSHA has accepted two newly Modified Ambient Aerosol Condensation Nuclei Counter (CNC) Quantitative Respirator Fit Test Protocols. The new protocols go into effect on September 26, 2019. The Modified CNC protocols reduce the time needed to…

ROUND ROCK, Texas, Sept. 28, 2019 /PRNewswire/ — ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) is pleased to join several organizations as a sponsor of the third annual National Penicillin Allergy Day, an awareness day to help educate the community on penicillin allergies and the importance…

LOS ANGELES, Sept. 28, 2019 /PRNewswire/ — Foot Locker and Fred Jordan Missions are excited to partner for one of Southern California’s largest Back-to-School Giveaways on the streets of Skid Row. More than 3,000 underprivileged children will receive new athletic shoes, clothes,…

HOUSTON and VANCOUVER, Sept. 28, 2019 /PRNewswire/ – ESSA Pharma Inc. (Nasdaq: EPIX) (TSXV: EPI), a pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today presented new preclinical data on ESSA’s lead Investigational New Drug (“IND”)…

RIYADH, Saudi Arabia, Sept. 28, 2019 /PRNewswire/ — On Wednesday, a British parliamentary delegation headed by MP John Woodcock was welcomed at the headquarters of the Saudi Development and Reconstruction Program for Yemen (SDRPY) in Riyadh. Also attending the meeting from the British…

FRAMINGHAM, Mass., Sept. 28, 2019 /PRNewswire/ — BERG, a clinical stage biopharmaceutical company that utilizes artificial intelligence (AI) and multi-omics to identify novel biology and disease modifying targets, today announced results from a predictive analysis of adverse events by…

SALT LAKE CITY, Sept. 28, 2019 /PRNewswire/ — Tolero Pharmaceuticals, Inc., a clinical-stage company focused on developing novel therapeutics for hematological and oncological diseases, today presented new data from the ongoing Phase 1 study evaluating the maximum tolerated dose (MTD) of…

THOUSAND OAKS, Calif., Sept. 27, 2019 /PRNewswire/ — Amgen (NASDAQ: AMGN) today announced new data from the ongoing Phase 1 study evaluating AMG 510 in patients with previously treated KRAS G12C-mutant solid tumors. The data include the first evidence of anti-tumor activity reported in…

NEW ORLEANS, Sept. 27, 2019 /PRNewswire/ — Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., have filed a class action lawsuit in the United States District Court for the District of Utah on behalf of purchasers of securities of…

NEW ORLEANS, Sept. 27, 2019 /PRNewswire/ — Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., have filed a class action lawsuit in the United States District Court for the Western District of Louisiana on behalf of shareholders who…